Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application Value of Novel PET Tracers Targeting CAF in ANCA-Associated Vasculitis

NCT07151521 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07151521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07151521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application Value of Novel PET Tracers Targeting CAF in ANCA-Associated Vasculitis
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
July 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anca-associated vasculitis